12.1 When New York Law Is Stricter Than Federal Law

The Stricter-Standard Rule on the NY MPJE

Throughout the exam, whenever New York and federal pharmacy law overlap, the rule is simple: the more restrictive standard controls, and a less restrictive federal floor never displaces a stricter New York ceiling. This is not a New York quirk — it flows from ordinary preemption doctrine. Federal law preempts state law only when Congress says so expressly, occupies the entire regulatory field, or when compliance with both bodies of law is a physical impossibility. Pharmacy practice is traditionally state-regulated, so New York routinely adds duties on top of the federal floor without conflicting with it. On the MPJE, when a stem asks what a pharmacist must do "under New York law" (or simply "in this jurisdiction"), and New York imposes a tighter requirement than federal law, the New York rule is the correct answer — even when a federal-law answer choice is also a true statement.

Reasoning Pattern: Three Questions to Ask

1. What is the call of the question? Is it asking about federal law, New York law, or "in this jurisdiction" (New York)?
2. What does each body of law actually require? Recall the federal floor, then the New York rule layered on top of it.
3. Which is stricter, and does the call ask for the stricter one? If New York adds a duty, restricts a quantity, or shortens a deadline relative to federal law, New York usually supplies the correct answer for a "must do" question.

Six Verified Examples of New York Stricter-Than-Federal Rules

1. Mandatory Electronic Prescribing — Broader Than Federal EPCS

Federal law (21 CFR Part 1311) permits electronic prescribing of controlled substances but never requires it. New York goes further in two ways: since March 27, 2016, under Public Health Law § 281, practitioners must electronically prescribe both controlled and non-controlled substances (subject to narrow statutory exceptions and a low-volume certification for prescribers issuing 25 or fewer prescriptions in a 12-month period). A paper prescription for a routine antibiotic — not just a controlled substance — can be non-compliant in New York even though federal law never regulated that prescription's transmission method at all.

2. Schedule II Emergency Oral Prescription — 72 Hours, Not 7 Days

Federal law allows a practitioner to phone in an emergency Schedule II prescription and then deliver a signed written or electronic follow-up within 7 days (21 CFR § 1306.11(d)). New York's parallel rule is tighter: under 10 NYCRR § 80.68(c), the practitioner must deliver the written or electronic follow-up prescription, marked "Authorization for emergency dispensing," within 72 hours of the oral authorization. If the pharmacist receives nothing within that window, the pharmacist must notify the Bureau of Narcotic Enforcement within 7 days of dispensing.

3. Schedule III-V Refill Limit on Large-Quantity Prescriptions

Federal law (21 CFR § 1306.22) allows a Schedule III, IV, or V prescription to be refilled up to 5 times within 6 months, with no rule tying refill count to the day supply prescribed. New York adds a restriction federal law does not have: under 10 NYCRR § 80.69(g), if the initial prescription is written for more than a 30-day supply, it may be refilled only once, regardless of how many refills the prescriber authorized on the face of the prescription.

4. Patient Counseling — Beyond OBRA '90's Medicaid-Only Origin

Federal OBRA '90 (42 U.S.C. § 1396r-8(g)) requires a prospective drug utilization review and an offer to counsel, but only for Medicaid outpatients. New York's 8 NYCRR § 63.6 applies to every patient regardless of payer: a pharmacist or pharmacy intern must personally counsel any new patient, any patient receiving a new medication, or any patient with a dose, strength, route, or directions change, documenting any refusal in the pharmacy's records; for prescriptions delivered off-premises (mail or delivery service), §63.6 instead requires a written offer to counsel with a reachable pharmacist's phone number.

5. Mandatory PMP Query for Practitioners — No Federal Counterpart at All

Federal law contains no requirement to query a prescription drug monitoring database before prescribing or dispensing — prescription monitoring programs are entirely creatures of state law. New York's Public Health Law § 3343-a(2) requires practitioners to consult the PMP registry before prescribing or dispensing a Schedule II, III, or IV controlled substance; Schedule V is excluded. Pharmacists are governed separately by § 3343-a(3): they are authorized, but not required, to consult the registry before dispensing, and may delegate that query to another pharmacist or a pharmacy intern at the same pharmacy. There is no comparably strict federal rule to "beat" here — New York's practitioner mandate exists on a topic federal law is entirely silent on.

6. Seven-Day Limit on Initial Acute-Pain Opioid Prescriptions

Federal law imposes no day-supply ceiling on an opioid prescribed for acute pain. New York's Public Health Law § 3331-a, effective July 22, 2016, limits a practitioner's initial Schedule II, III, or IV opioid prescription for acute pain to a 7-day supply; chronic pain, cancer care, hospice, and palliative care are excepted, and any subsequent encounter for the same pain may generate a normal renewal or new prescription.

Spotting the Pattern on Exam Day

Notice that these six examples fall into two distinct patterns. In examples 1-4, New York and federal law regulate the same topic, and New York simply sets a tighter number or a broader scope. In examples 5-6, federal law is silent — there is no federal rule to compare against, so "New York is stricter" really means "New York imposes a duty federal law never addresses." Both patterns produce the same MPJE answer strategy: when the stem asks what New York law requires, apply the New York-specific rule even if a federal-sounding distractor is technically true of federal law. Never assume federal silence means no duty exists — check whether New York filled the gap.